The new platform helps Life Sciences organizations manage fee-for-service HCP engagements through structured workflows, FMV governance, participant validation, documentation and transparency reporting readiness. MOUNT ARLINGTON, N.J., Aug. 4, 2026 /PRNewswire/ -- MedPro Systems today announced the launch of EngagePro, a highly configurable HCP engagement management platform designed to help Life Sciences organizations plan, approve, execute, govern and close out fee-for-service HCP engagements t

Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across eight major disorders with high unmet treatment needs in a single clinical framework Study indications include Anorexia Nervosa, Body Dysmorphic Disorder, Obsessive Compulsive Disorder, Generalised Anxiety Disorder, Post Traumatic Stress Disorder, Treatment-Resistant Depression, Fibromyalgia and I

The MedTech veteran who scaled 1RF ablation for Barrett's Esophagus into a $40 million business takes the helm as Aqua treats its first patient in the U.S. pilot study of PIMA for type 2 diabetes. PLEASANTON, Calif., Aug. 4, 2026 /PRNewswire/ -- Aqua Medical, Inc., a clinical-stage medical device company developing minimally invasive endoscopic therapies for type 2 diabetes and Barrett's Esophagus, today announced the appointment of Robert "Bob" Haggerty as President and Chief Executive Officer,

The phenol-free magnetic bead workflow includes DNase treatment to optimize cfRNA recovery for downstream sequencing and amplification IPSWICH, Mass., Aug. 4, 2026 /PRNewswire/ -- New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, which enables isolation of low-abundance, circulating cell-free RNA (cfRNA) and exome-associated RNA from biofluids including plasma, serum, urine and cerebrospinal fluid. The kit complements the Monarch Mag Cell-f

BOXBOROUGH, Mass., Aug. 4, 2026 /PRNewswire/ -- Q-Square Business Intelligence, Corp. (Q2BI), a global clinical data intelligence company headquartered in Boxborough, Massachusetts, today announced the opening of new offices in Taipei, Kuala Lumpur, and Melbourne. The expansion marks another milestone in Q2BI's international growth and strengthens its presence across the Asia-Pacific region. The new offices build upon Q2BI's established operations and expand its global network of clinical, scien

Now commercially available, the medium cut-off dialyzer expands access to enhanced middle molecule removal through existing dialysis infrastructure OSAKA, Japan and BRIDGEWATER, N.J., Aug. 4, 2026 /PRNewswire/ -- NIPRO CORPORATION, through its U.S.-based subsidiary Nipro Medical Corporation, today announced the U.S. commercial launch of ELISIO-HX, a medium-cutoff dialyzer featuring super high-flux membrane technology. Enabled by the recent U.S. Food and Drug Administration (FDA) 510(k) clearance

In the news release, Virginia Cancer Specialists Clinical Research Leader Receives SCRI Site Partnership Excellence Award, issued 04-Aug-2026 by Virginia Cancer Specialists over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Virginia Cancer Specialists Clinical Research Leader Receives SCRI Site Partnership Excellence Award FAIRFAX, Va., Aug. 4, 2026 /PRNewswire/ -- Virginia Cancer Specialists,

Evidence-based education platform and companion podcast provide clinicians with structured training in infrared imaging for sports and occupational medicine BIRMINGHAM, Ala., Aug. 4, 2026 /PRNewswire/ -- Vizbodx, Inc., a developer of infrared thermal intelligence technology for sports medicine, today announced the launch of Vizbodx Academy, an invitation-only education platform created to establish a consistent, evidence-based educational standard for clinicians adopting infrared imaging. The co

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- AEYE Health, the leader in ophthalmic AI and retinal diagnostics and the developer of AEYE-DS, today announced the publication of a new study in the British Journal of Ophthalmology. The prospective, real-world study demonstrates that the AEYE Diagnostic Screening (AEYE-DS) system integrates into busy endocrinology workflows, achieving 96% success rate ("imageability") without the need for pharmacological eye dilation, using the Topcon NW500 non-mydriatic c

BOCA RATON, Fla., Aug. 4, 2026 /PRNewswire/ -- How does laser therapy offer a gentler way to treat periodontal disease? That question is explored in a new HelloNation article featuring Dr. Ernest Orphanos of Center 4 Smiles in Boca Raton, FL. The article breaks down how laser gum disease treatment is changing the way dental professionals manage chronic gum conditions by focusing on precision, comfort, and healing. Continue Reading Dr. Ernest Orphanos - Board Certified Periodontist, Center 4 Smil